Postmarketing Surveillance Study for Quadrivalent Influenza Vaccine (VaxigripTetra Inj.) in Subjects Aged 3 Years Old and Above

Safety Surveillance of VaxigripTetra® and Efluelda® Influenza Vaccines in Europe During the Influenza Season 2022/23

NCT05568979 ·Status: COMPLETED

Safety and Immunogenicity of GPO Seasonal Tetravalent Inactivated Split Virion Influenza Vaccine in Healthy Thais

NCT05895955 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

Phase Ⅲ, Clinical Trial to Compare an Inactivated Quadrivalent Influenza Vaccine and a Licensed Vaccine in Chile

NCT05494047 ·Status: UNKNOWN ·Phase: PHASE3

Safety, Tolerability, and Immunogenicity of GC3106 (Quadrivalent Cell-culture Based Influenza Vaccine)

NCT02249221 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Study of Sanofi Pasteur's Intradermal Influenza Vaccine (IDflu™) in Adults and Elderly in Korea

NCT01215669 ·Status: COMPLETED ·Phase: PHASE4

Safety Study of Quadrivalent Subunit Influenza Vaccine in People Aged 3 Years and Older

NCT07332689 ·Status: COMPLETED

Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccine MRT5413 in Adult Participants18 Years of Age and Older

NCT05650554 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Evaluate the Safety and Efficacy of Quadrivalent Influenza in Real-world Situations.

NCT06334510 ·Status: COMPLETED

Immunogenicity and Safety of Quadrivalent Influenza Vaccine in Children Aged 6~35 Months

NCT03020628 ·Status: COMPLETED ·Phase: PHASE3

Phase Ⅲ Clinical Study of Quadrivalent Influenza Virus Split Vaccine

NCT05642078 ·Status: COMPLETED ·Phase: PHASE3

Study Describing the Immunogenicity and Safety of Quadrivalent Recombinant Influenza Vaccine (RIV4) Versus a Licensed Quadrivalent-inactivated Influenza Vaccine (IIV4) (Fluarix® Quadrivalent) in Participants 18 Years of Age and Older in South Korea

NCT05144945 ·Status: COMPLETED ·Phase: PHASE3

Phase 3 Study to Evaluate the Immunogenicity and Safety of Inactived Split Influenza Vaccine in Healthy Korea Infants

NCT04381689 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Post-marketing Study to Monitor the Safety of a MF59-adjuvanted Influenza Vaccine Administered in Korean Subjects Aged 65 Years or Older

NCT01222403 ·Status: COMPLETED ·Phase: PHASE4

Enhanced Safety Surveillance of GlaxoSmithKline's (GSK's) Quadrivalent Seasonal Influenza Vaccines During the 2018/19 Influenza Season

NCT03688620 ·Status: COMPLETED ·Phase: PHASE4

Safety and Immunogenicity Study of Quadrivalent Influenza Virus Vaccine in Healthy People Aged Years 3-60

NCT02806804 ·Status: UNKNOWN ·Phase: PHASE3

Study of Safety and Immunogenicity of a Quadrivalent Influenza Vaccine in Healthy Adults Age 65-75 Years

NCT02247362 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

A Study to Evaluate the Efficacy and Safety of 'GC3110A(QIV)' in Healthy Children

NCT02541253 ·Status: COMPLETED ·Phase: PHASE3

Safety Surveillance of VaxigripTetra® and Efluelda® Influenza Vaccines in Europe During the Influenza Season 2023/24

NCT06059456 ·Status: COMPLETED

Influenza Vaccine (Split Virion), Inactivated, Quadrivalent in Pregnant Women

NCT07211152 ·Status: RECRUITING ·Phase: PHASE3

Clinical Trial to Evaluate the Safety and Immunogenicity of Quadrivalent Influenza Vaccine (7.5μg/0.25ml)

NCT03859141 ·Status: COMPLETED ·Phase: PHASE3

Safety Surveillance of VaxigripTetra® and Efluelda® Influenza Vaccines in Europe During the Influenza Season 2021/22

NCT05078060 ·Status: COMPLETED

Phase 1 Safety Study of Recombinant Influenza Vaccine for Prevention

NCT02015494 ·Status: UNKNOWN ·Phase: PHASE1

A Phase I/IIa Study of GC3110A (Quadrivalent Influenza Vaccine)

NCT02121782 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Phase 3 Study to Evaluate the Immunogenicity and Safety of Inactivated Split Influenza Vaccine in Healthy Korea Children

NCT02263131 ·Status: COMPLETED ·Phase: PHASE3

Safety and Immunogenicity of a Monovalent mRNA Vaccine Encoding Influenza Hemagglutinin in Adult Participants 18 Years of Age and Older

NCT06118151 ·Status: COMPLETED ·Phase: PHASE1